Core B - Bioinformatics Research Resource. The objectives of this Research Resource (Core) are as follows: provide bioinformatics capabilities to support the proposed Research Projects, to enable data sharing, and to provide the capacity to link with the BETRNet Coordination Center. This Core will also address timely sharing of data, including data on the availability of biospecimens at the Research Center, and their submission for centralized data collection at the Coordinating Center. The Core B investigators will work closely with the Project 1 investigators to choose a panel of candidate genes that will be studied in larger sets of samples at the protein level using tissue microarrays in Aim 2. A smaller subset of these genes would then be further selected to be part of a screening strategy to guide tissue biopsy collection in patients, and so we seek candidate genes that can be expected to perform well at discriminating high-grade dysplasia in this ultimate task. In addition, the Core B investigators will work closely with the Project 2 investigators to support statistical analyses for the validation of candidate peptides on purified protein targets and cell lines engineered to overexpress these targets, including T-tests or ANOVAs, and to support the study design for the Phase 1 clinical studies of the peptide panel. Moreover, the Core B investigators will work closely with the Core C investigators to validate the panel of peptides on endoscopically resected specimens of esophageal mucosa by comparing the log-transformed intensity measurements between the different histological classifications (squamous, metaplasia, low-grade dysplasia (LGD), high-grade dysplasia (HGD), and adenocarcinoma) using 1-way ANOVAs and painwise comparisons between the two higher-grade categories (HGD, adenocarcinoma).

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Ann Arbor
United States
Zip Code
Chen, Jing; Gao, Zhenghong; Li, Gaoming et al. (2018) Dual-modal in vivo fluorescence and photoacoustic imaging using a heterodimeric peptide. Chem Commun (Camb) 54:13196-13199
Joshi, Bishnu P; Wang, Thomas D (2018) Targeted Optical Imaging Agents in Cancer: Focus on Clinical Applications. Contrast Media Mol Imaging 2018:2015237
Rubenstein, Joel H; Waljee, Akbar K; Dwamena, Ben et al. (2018) Yield of Higher-Grade Neoplasia in Barrett's Esophagus With Low-Grade Dysplasia Is Double in the First Year Following Diagnosis. Clin Gastroenterol Hepatol 16:1529-1530
Tavakkoli, Anna; Appelman, Henry D; Beer, David G et al. (2018) Use of Appropriate Surveillance for Patients With Nondysplastic Barrett's Esophagus. Clin Gastroenterol Hepatol 16:862-869.e3
Stachler, Matthew D; Camarda, Nicholas D; Deitrick, Christopher et al. (2018) Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma. Gastroenterology 155:156-167
Jiang, Yang; Gong, Yuanzheng; Rubenstein, Joel H et al. (2017) Toward real-time quantification of fluorescence molecular probes using target/background ratio for guiding biopsy and endoscopic therapy of esophageal neoplasia. J Med Imaging (Bellingham) 4:024502
Savastano, Luis E; Seibel, Eric J (2017) Scanning Fiber Angioscopy: A Multimodal Intravascular Imaging Platform for Carotid Atherosclerosis. Neurosurgery 64:188-198
Zhou, Juan; He, Lei; Pang, Zhijun et al. (2017) Identification and validation of FGFR2 peptide for detection of early Barrett's neoplasia. Oncotarget 8:87095-87106
Savastano, Luis E; Zhou, Quan; Smith, Arlene et al. (2017) Multimodal laser-based angioscopy for structural, chemical and biological imaging of atherosclerosis. Nat Biomed Eng 1:
Joshi, Bishnu P; Zhou, Juan; Pant, Asha et al. (2016) Design and Synthesis of Near-Infrared Peptide for in Vivo Molecular Imaging of HER2. Bioconjug Chem 27:481-94

Showing the most recent 10 out of 45 publications